세계의 바이오 분석 시험 서비스 시장 규모는 2022년 29억 달러, 2023년 32억 달러에서 예측기간 중 15.2%의 CAGR로 성장하여 2028년에는 66억 달러 규모로 성장할 것으로 예측됩니다.
서비스 종류별로는 세포 기반 어세이 부문이 2022년 5억 7,250만 달러, 2023년 6억 5,300만 달러에서 15.7%의 CAGR로 성장하여 2028년에는 14억 달러 규모로 성장할 것으로 예측됩니다. 또한 생물학적 동등성 및 생체이용률 연구 부문은 2022년 5억 2,360만 달러, 2023년 5억 9,750만 달러에서 16.3%의 CAGR로 성장하여 2028년에는 13억 달러 규모로 성장할 것으로 예측됩니다.
세계의 바이오 분석 시험 서비스 시장을 조사했으며, 시장 및 기술 개요, 시장 영향요인 분석, 규제 상황, 시장 규모 추정과 예측, 각종 부문·지역별 상세 분석, 기술 및 특허 동향, ESG 전개, 경쟁 상황, 주요 기업 개요 등을 정리했습니다.
목차
제1장 서론
제2장 요약과 하이라이트
시장 전망
시장 요약
제3장 시장 개요
기술 배경
액체 크로마토그래피 질량 분석(LC-MS)
유도 결합 플라즈마 질량 분석(ICP-MS)
핵자기공명(NMR)
모세관 전기영동(CE)
가스 크로마토그래피 질량 분석(GC-MS)
제4장 시장 역학
시장 역학
성장 촉진요인
성장 억제요인
기회
COVID-19가 바이오 분석 시험 서비스 시장에 미치는 영향
규제 상황
PESTEL 분석
의약품 바이오 분석의 성공요인
고성능 기기에 대한 투자
최신 기술의 지속적 평가
용량 증가 시험이 환자 안전에 미치는 영향
규제 환경의 변화
제5장 세계의 바이오 분석 시험 서비스 시장 : 서비스 유형별
약물동태 연구
생물학적 동등성 및 생체이용률 연구
바이오마커 검사 서비스
세포 기반 어세이
바이러스 검사
방법 개발, 최적화, 검증
혈청학, 면역원성, 중화 항체
기타
제6장 세계의 바이오 분석 시험 서비스 시장 : 용도별
종양
심혈관질환
면역
신경내과
감염증
기타
제7장 세계의 바이오 분석 시험 서비스 시장 : 최종사용자별
제약회사 및 바이오의약품 회사
CRO
CDMO
기타
제8장 세계의 바이오 분석 시험 서비스 시장 : 지역별
북미
유럽
아시아태평양
기타 지역
제9장 ESG 전개
ESG : 서론
바이오 분석 시험 서비스 업계에서 ESG의 중요성
ESG 평가와 지표 : 데이터 이해
바이오 분석 시험 서비스 업계의 ESG 실천
환경면 퍼포먼스
사회면 퍼포먼스
지배구조면 퍼포먼스
향후 동향
BCC에 의한 견해
제10장 새로운 기술과 개발
새로운 기술
바이오 분석 샘플 조제 기술의 최근 개발
제11장 M&A 분석
제12장 경쟁 정보
주요 기업 순위
기업이 채용하는 주요 전략
확대
신제품 발매
협업
기타
제13장 기업 개요
AFFIGENIX BIOSOLUTIONS PVT LTD
ALMAC GROUP
ARAGEN LIFE SCIENCES PVT LTD
BIOANALYTICAL SYSTEMS INC.
BIONEEDS INDIA PRIVATE LTD
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
EUROFINS SCIENTIFIC SE
INOTIV INC.(ENVIGO)
INTERTEK GROUP PLC
LABORATORY CORP. OF AMERICA HOLDINGS
PACE ANALYTICAL
PACIFIC BIOLABS
SARTORIUS AG
SGS S.A.
SYNEOS HEALTH
WUXI APPTEC CO. LTD
KSM
영문 목차
영문목차
Highlights:
The global bioanalytical testing services market reached $2.9 billion in 2022, should reach $3.2 billion by 2023 and $6.6 billion by 2028 with a compound annual growth rate (CAGR) of 15.2% during the forecast period of 2023-2028.
Cell-Based Assays segment of the global bioanalytical testing services market reached $572.5 million in 2022, should reach $653.0 million by 2023 and $1.4 billion by 2028 with a CAGR of 15.7% during the forecast period of 2023-2028.
Bioequivalence & Bioavailability Studies segment of the global bioanalytical testing services market reached $523.6 million in 2022, should reach $597.5 million by 2023 and $1.3 billion by 2028 with a CAGR of 16.3% during the forecast period of 2023-2028.
Report Scope:
The report's scope includes an overview of the global market on bioanalytical testing services and an analysis of global market trends, using 2022 as the base year and forecasting 2023 through 2028 with a compound annual growth rate (CAGR) projection.
The report analyzes leading services, applications, end user, and product details for the bioanalytical testing services market. Leading market players' profiles, specific services, financial information, and recent market activities are provided. This report also assesses companies' mergers & acquisitions and funding activities and their impact in the face of the competitive environment. The report details the bioanalytical testing services market based on service type, application, and end user. The market is segmented into pharmacokinetics studies, bioequivalence and bioavailability studies, biomarker testing services, cell-based assays, virology testing, method development, optimization & validation, serology, immunogenicity, and neutralizing antibodies, and others.
The market is categorized as oncology, immunology, neurology, infectious diseases, cardiovascular diseases, and others. The market is segmented into pharmaceutical and biopharmaceutical companies, contract research organizations, contract development and manufacturing organizations, and others. The report also consists of the impact of the COVID-19 pandemic on this market. Regional analysis includes North America (U.S., Canada, Mexico), Europe (UK, Germany, France, Spain, Italy, Rest of Europe), Asia-Pacific (China, India, Japan, and Rest of Asia-Pacific), and the Rest of the World (South America, and the Middle East and Africa).
Report Includes:
45 data tables and 44 additional tables
An overview of the global market for bioanalytical testing services
An estimate of market size and analyses of global market trends, with data from 2023, estimates for 2024, and projections of compound annual growth rates (CAGRs) through 2028
Characterization and quantification of the global market for bioanalytical testing services on the basis of technology, application, end user and region
Information on sample requirements for discovery bioanalysis, preclinical and clinical bioanalysis and descriptions of toxicokinetic and pharmacokinetics studies
Coverage of technological advances in the drug discovery process and information on investments in the R&D of biologics, biosimilars and other specialty drugs
An examination of the drivers and constraints that will shape the market, and a discussion of the upcoming market opportunities in order to forecast the market by its segments and sub-segments
An assessment of existing products as well as those in the pipelines of the major players in the market
Coverage of recent advances, emerging technologies and ongoing developments in the industry
An evaluation of key industry acquisitions and strategic alliances, and an analysis of the market shares of the leading companies
Company profiles of major players within the industry, including SGS S.A., Intertek Group PLC, Eurofins Scientific SE, Charles River International Laboratories, Inc., Inotiv Inc., and WuXi AppTec
Table of Contents
Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Methodology
Information Sources
Geographic Breakdown
Chapter 2 Summary and Highlights
Market Outlook
Market Summary
Chapter 3 Market Overview
Introduction
Technology Background
Liquid Chromatography-Mass Spectrometry (LC-MS)
Inductively Coupled Plasma Mass Spectrometry (ICP-MS)
Nuclear Magnetic Resonance (NMR)
Capillary Electrophoresis (CE)
Gas Chromatography-Mass Spectrometry (GC-MS)
Chapter 4 Market Dynamics
Market Dynamics
Drivers
Restraints
Opportunities
Impact of COVID-19 on the Bioanalytical Testing Services Market
Regulatory Landscape
PESTEL Analysis
Success Factors in Pharmaceutical Bioanalysis
Investing in High Capability Equipment
Constant Evaluation of the Latest Technologies
Considering the Impact of Rising Dose Trials on Patient Safety
Keeping a Track of Changes in Regulatory Environment
Chapter 5 Global Bioanalytical Testing Services Market by Service Type
Pharmacokinetics Studies
Bioequivalence and Bioavailability Studies
Biomarker Testing Services
Cell-Based Assays
Virology Testing
Method Development, Optimization & Validation
Serology, Immunogenicity, and Neutralizing Antibodies
Others
Chapter 6 Global Bioanalytical Testing Services Market by Application
Oncology
Cardiovascular Diseases
Immunology
Neurology
Infectious Diseases
Others
Chapter 7 Global Bioanalytical Testing Services Market by End User
Pharmaceutical and Biopharmaceutical Companies
Contract Research Organizations (CROs)
Contract Development and Manufacturing Organizations (CDMOs)
Others
Chapter 8 Global Bioanalytical Testing Services Market by Region
North America
Europe
Asia-Pacific
Rest of the World
Chapter 9 ESG Developments
Introduction to ESG
Importance of ESG in Bioanalytical Testing Services Industry
ESG Ratings and Metrics: Understanding the Data
ESG practices in the Bioanalytical Testing Services Industry
Environmental Performance
Social Performance
Governance Performance
Future Trends
BCC Research Viewpoint
Chapter 10 Emerging Technologies and Developments
Emerging Technologies
Recent Developments in Bioanalytical Sample Preparation Techniques
